167 related articles for article (PubMed ID: 2287945)
21. Articular cartilage superficial zone protein (SZP) is homologous to megakaryocyte stimulating factor precursor and Is a multifunctional proteoglycan with potential growth-promoting, cytoprotective, and lubricating properties in cartilage metabolism.
Flannery CR; Hughes CE; Schumacher BL; Tudor D; Aydelotte MB; Kuettner KE; Caterson B
Biochem Biophys Res Commun; 1999 Jan; 254(3):535-41. PubMed ID: 9920774
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-4, an inhibitor of cartilage breakdown in bovine articular cartilage explants.
Yeh LA; Augustine AJ; Lee P; Riviere LR; Sheldon A
J Rheumatol; 1995 Sep; 22(9):1740-6. PubMed ID: 8523355
[TBL] [Abstract][Full Text] [Related]
23. Influence of interleukin-1 on the morphology and proteoglycan metabolism of cultured bovine articular chondrocytes.
Aydelotte MB; Raiss RX; Caterson B; Kuettner KE
Connect Tissue Res; 1992; 28(1-2):143-59. PubMed ID: 1628488
[TBL] [Abstract][Full Text] [Related]
24. Degradation of cartilage proteoglycan by human leukocyte granule neutral proteases--a model of joint injury. I. Penetration of enzyme into rabbit articular cartilage and release of 35SO4-labeled material from the tissue.
Janoff A; Feinstein G; Malemud CJ; Elias JM
J Clin Invest; 1976 Mar; 57(3):615-24. PubMed ID: 129482
[TBL] [Abstract][Full Text] [Related]
25. Age related changes in the turnover of proteoglycans from explants of bovine articular cartilage.
Brand HS; de Koning MH; van Kampen GP; van der Korst JK
J Rheumatol; 1991 Apr; 18(4):599-605. PubMed ID: 2066951
[TBL] [Abstract][Full Text] [Related]
26. The pathobiology of focal lesion development in aging human articular cartilage and molecular matrix changes characteristic of osteoarthritis.
Squires GR; Okouneff S; Ionescu M; Poole AR
Arthritis Rheum; 2003 May; 48(5):1261-70. PubMed ID: 12746899
[TBL] [Abstract][Full Text] [Related]
27. The effect of retinoic acid on proteoglycan turnover in bovine articular cartilage cultures.
Campbell MA; Handley CJ
Arch Biochem Biophys; 1987 Oct; 258(1):143-55. PubMed ID: 3662538
[TBL] [Abstract][Full Text] [Related]
28. Expression of Sox9 and type IIA procollagen during attempted repair of articular cartilage damage in a transgenic mouse model of osteoarthritis.
Salminen H; Vuorio E; Säämänen AM
Arthritis Rheum; 2001 Apr; 44(4):947-55. PubMed ID: 11315934
[TBL] [Abstract][Full Text] [Related]
29. Regulation of metabolism of the chondrocytes in articular cartilage--an hypothesis.
Phadke K
J Rheumatol; 1983 Dec; 10(6):852-60. PubMed ID: 6663591
[TBL] [Abstract][Full Text] [Related]
30. Production of cytokines by chondrocytes and its role in proteoglycan degradation.
Shinmei M; Masuda K; Kikuchi T; Shimomura Y; Okada Y
J Rheumatol Suppl; 1991 Feb; 27():89-91. PubMed ID: 2027138
[TBL] [Abstract][Full Text] [Related]
31. N-terminal sequence of proteoglycan fragments isolated from medium of interleukin-1-treated articular-cartilage cultures. Putative site(s) of enzymic cleavage.
Loulakis P; Shrikhande A; Davis G; Maniglia CA
Biochem J; 1992 Jun; 284 ( Pt 2)(Pt 2):589-93. PubMed ID: 1599440
[TBL] [Abstract][Full Text] [Related]
32. Effects of catabolic and anabolic cytokines on proteoglycan biosynthesis in young, old and osteoarthritic canine cartilage.
Venn G; Lauder RM; Hardingham TE; Muir H
Biochem Soc Trans; 1990 Oct; 18(5):973-4. PubMed ID: 2083777
[No Abstract] [Full Text] [Related]
33. Factors involved in the regulation of proteoglycan metabolism in articular cartilage.
Morales TI; Hascall VC
Arthritis Rheum; 1989 Oct; 32(10):1197-201. PubMed ID: 2679560
[No Abstract] [Full Text] [Related]
34. Age-related changes in cartilage proteoglycans: quantitative electron microscopic studies.
Buckwalter JA; Roughley PJ; Rosenberg LC
Microsc Res Tech; 1994 Aug; 28(5):398-408. PubMed ID: 7919527
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase.
Billinghurst RC; Wu W; Ionescu M; Reiner A; Dahlberg L; Chen J; van Wart H; Poole AR
Arthritis Rheum; 2000 Mar; 43(3):664-72. PubMed ID: 10728761
[TBL] [Abstract][Full Text] [Related]
36. The effect of naproxen and interleukin-1 on proteoglycan catabolism and on neutral metalloproteinase activity in normal articular cartilage in vitro.
Glazer PA; Rosenwasser MP; Ratcliffe A
J Clin Pharmacol; 1993 Feb; 33(2):109-14. PubMed ID: 8440758
[TBL] [Abstract][Full Text] [Related]
37. Age-related changes in the composition, the molecular stoichiometry and the stability of proteoglycan aggregates extracted from human articular cartilage.
Wells T; Davidson C; Mörgelin M; Bird JL; Bayliss MT; Dudhia J
Biochem J; 2003 Feb; 370(Pt 1):69-79. PubMed ID: 12431185
[TBL] [Abstract][Full Text] [Related]
38. Accumulation of advanced glycation endproducts reduces chondrocyte-mediated extracellular matrix turnover in human articular cartilage.
DeGroot J; Verzijl N; Jacobs KM; Budde M; Bank RA; Bijlsma JW; TeKoppele JM; Lafeber FP
Osteoarthritis Cartilage; 2001 Nov; 9(8):720-6. PubMed ID: 11795991
[TBL] [Abstract][Full Text] [Related]
39. Effect of pulsed electromagnetic fields on proteoglycan biosynthesis of articular cartilage is age dependent.
Bobacz K; Graninger WB; Amoyo L; Smolen JS
Ann Rheum Dis; 2006 Jul; 65(7):949-51. PubMed ID: 16769781
[TBL] [Abstract][Full Text] [Related]
40. Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage.
Kobayashi M; Squires GR; Mousa A; Tanzer M; Zukor DJ; Antoniou J; Feige U; Poole AR
Arthritis Rheum; 2005 Jan; 52(1):128-35. PubMed ID: 15641080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
